Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Centre hospitalier de l'Université de Montréal (CHUM)

12 clinical trials · 12 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Centre hospitalier de l'Université de Montréal (CHUM)

RECRUITINGPhase 3NCT03594760

PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

Prostate cancer (PCa) is the most common non-skin malignancy and the third leading cause of cancer death in North American men. The accurately mapped metastatic state is a...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 10001 location
Prostate Cancer
RECRUITINGNCT05355363

Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay

The primary aim of this study is to determine the rate of total metachronous advanced neoplasia (TMAN) detection after index detection of serrated lesions (SL) \[sessile serrated...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 7301 location
Colorectal CancerColon Adenoma
RECRUITINGNCT06345508

Early Detection of Liver Cancer by QUS

Worldwide, liver cancers are the third most common cause of cancer mortality. Even when liver cancer is suspected by blood tests, imaging is required to determine the location,...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 3281 location
Hepatocellular CarcinomaLiver Cancer
RECRUITINGPhase 2NCT04901234

Adaptive RadioTherapy for OroPharynx Cancer

This is a phase II randomized trial, where patients with histologically proven squamous cell carcinoma of oropharynx that have primary tumor (T3 - T4) in place, treated with...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1202 locations
Oropharynx CancerRadiotherapy; ComplicationsRadiotherapy Side Effect+2
RECRUITINGNCT04973397

Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study

The proportion of noncardiac surgeries performed as same-day surgery is increasing worldwide, with more complex surgeries being performed on higher risk patients in the outpatient...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1500016 locations
Preoperative CareSurgery--ComplicationsMyocardial Infarction
RECRUITINGNCT04951804

EUS-CPN With and Without Bupivacaine

Endoscopic ultrasound (EUS) allows EUS-guided trans gastric injection of absolute alcohol around the base of the celiac plexus (celiac plexus neurolysis (EUS-CPN)), to help...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1801 location
Pancreatic Cancer
RECRUITINGPhase 2NCT05785065

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

The goal of this pilot study is to assess the feasibility of a larger study on the efficacy of mycophenolate mofetil in people diagnosed with systemic sclerosis with mild lung...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 353 locations
Systemic Sclerosis With Lung InvolvementSystemic SclerosisInterstitial Lung Disease
RECRUITINGPhase 2NCT07030920

Reducing Systemic Inflammation in People on Antiretroviral Therapy

This randomized, open-label clinical trial will evaluate whether adding fostemsavir to current antiretroviral therapy can reduce the risk of cardiovascular disease in people with...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1501 location
Human Immunodeficiency Virus (HIV)Cardiovascular Risk Factor
RECRUITINGPhase 1 / Phase 2NCT05180994

Topical Infliximab in Eyes With Penetrating Keratoplasty

Penetrating keratoplasty is a cornea surgery involving several inflammatory complications, of which the most important is glaucoma. Researchers wish to determine whether it is...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 501 location
Glaucoma Following Surgery
RECRUITINGNCT02084745

Timing of Glaucoma Drainage Device With Boston Keratoprosthesis

Boston keratoprosthesis (KPro) is a piece of specialized plastic that replace sick cornea (transparent structure at the front of the eye) in patients who have failed or those who...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 401 location
Corneal TransplantationGlaucoma
RECRUITINGNCT04232982

The Role of Transscleral Cyclophotocoagulation in Patients Undergoing a Boston Keratoprosthesis

The Boston keratoprosthesis (KPro) is a special plastic device that is used to replace a sick cornea (transparent part of the eye, in front of the iris) in order to restore vision...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 201 location
GlaucomaEye DiseasesCornea Disease
RECRUITINGNCT04699864

Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM

This prospective study aims to validate if NeoRetina, an artificial intelligence algorithm developped by DIAGNOS Inc. and trained to automatically detect the presence of diabetic...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 6301 location
Diabetic RetinopathyDiabetic Macular EdemaDiabetic Maculopathy